ARTICLE | Company News
Myriad and Bayer expand proteomics deal
December 13, 2000 8:00 AM UTC
MYGN and Bayer (DAX:BAYG) extended and expanded their 1997 collaboration to develop products to treat dementia using MYGN's ProNet proteomics technology (see BioCentury, Nov. 24, 1997). The collaborat...